‘The Great Stem Cell Dilemma” — the title of a long, informative article in Fortune Magazine last month (October 8, 2012, Jeffrey M. O’Brien) that pointed out the progress being made in regenerative medicine, mostly using stem cells, though countered by the difficulty in getting the kind of large, longer-term financing needed to take this from the lab to potential mainstream use.
via www.a-remedy-for-death.com
This is from my other blog, background and research on my speculative medical technothriller, A REMEDY FOR DEATH